Aniline-2,5-disulfonic acid based new proton transfer salt and new Co(II) and Cu(II) coordination polymers: synthesis, structural and antimicrobial studies


Büyükkıdan N., Turgut S. B., İlkimen H., SARI M., GÜLBANDILAR A.

Chemical Papers, 2024 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1007/s11696-024-03544-w
  • Dergi Adı: Chemical Papers
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core
  • Anahtar Kelimeler: Aniline-2,5-disulfonic acid, Antimicrobial, Metal complexes, Salt, Single crystal XRD
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

The new salt named 4,4'-thiobis(pyridin-1-ium) aniline-2,5-disulfonate (1), (H2DPS)2+(ADSA)2− (1), was synthesized by the reaction of 1,2-di(pyridin-4-yl)disulfane (DPDS) and aniline-2,5-disulfonic acid (H2ADSA) at reflux temperature. Also, new coordination polymers formulated as {[M(DPS)2(H2O)2]}n(ADSA)·4H2O {DPS = di(pyridin-4-yl)sulphane, M = Co(II) (2) and Cu(II) (3)} were synthesized from the salt 1. The structure of 1 was clarified using methods such as elemental analysis, nuclear magnetic resonance, ultraviolet–visible and infrared spectroscopy. For the structural examinations of 2 and 3, magnetic susceptibility, spectroscopic analysis and an X-ray study were used. X-ray analysis showed that the DPS ligand coordinated to Co(II) in complex 2 and Cu(II) in complex 3. In both coordination polymers, the coordination sphere of the M(II) ion with six coordination numbers consists of four N atoms of four DPS molecules and two O atoms of two water molecules, resulting in a distorted octahedral geometry. Antibacterial properties were tested against Bacillus subtilis, Listeria monocytogenes (ATCC 7644), Staphylococcus aureus (NRRL B-767), Enterococcus faecalis (ATCC 29212), Pseudomonas aeruginosa (ATCC 27853), Escherichia coli (ATCC 25922) and were tested against yeast Candida albicans (F89). The antibacterial activities of the compounds were compared with the control drugs Cefepime, Levofloxacin and Vancomycin and their antifungal activities were compared with the antifungal reference drug Fluconazole.